| 000 | 01830cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030820.0 | ||
| 008 | 130408s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.28.M.Sc.2012.Ha.E | ||
| 100 | 0 | _aHanan Mohamed Naguib Ahmed Soliman | |
| 245 | 1 | 0 |
_aEffect of insulin glargine on glycemic control in adolescents with type 1 diabetes / _cHanan Mohamed Naguib Ahmed Soliman ; Supervised Mona Mamdouh Hassan , Maha Mohsen Amin , Hend Mehawed Abdellatef |
| 246 | 1 | 5 | _aتأثير الانسولين جلارجين على التحكم بمستوى السكر بالدم لدى المراهقين المصابين بالسكر من النوع الأول |
| 260 |
_aCairo : _bHanan Mohamed Naguib Ahmed Soliman , _c2012 |
||
| 300 |
_a146P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Pediatrics | ||
| 520 | _aTo study the role of long acting insulin analog (insulin glargine) in glycemic control and to compare its efficacy and cost versus intermediate acting insulin (NPH) in a country with limited resources like Egypt . It is a non - controlled interventional clinical trial that included twenty seven adolescents (10-18 years) , with type 1 diabetes mellitus of one or more years duration | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aInsulin promotor factor | |
| 653 | 4 | _aMultiple daily injection | |
| 653 | 4 | _aProtein 2-D | |
| 700 | 0 |
_aHend Mehawed Abdellatef , _eSupervisor |
|
| 700 | 0 |
_aMaha Mohsen Amin , _eSupervisor |
|
| 700 | 0 |
_aMona Mamdouh Hassan , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42520 _d42520 |
||